Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

Federal cannabis compliance is on the brink of a seismic shift. The legislative fight over the federal definition of hemp is heating up in Congress, with the proposed HEMP Act of 2025 (S.2112) and parallel Farm Bill and appropriations debates squarely targeting intoxicating hemp products like delta-8 THC and THCa. For cannabis businesses, investors, and regulators, understanding the stakes and potential impacts is critical for strategic planning and compliance.
The Agricultural Improvement Act of 2018—widely known as the 2018 Farm Bill—revolutionized cannabis policy by removing “hemp” from the federal definition of marijuana. It defined hemp as:
“…the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.” ([source])
This charted a legal path for industrial hemp cultivation and product development nationwide. Critically, however, this definition focused exclusively on delta-9 THC, leaving a gap for other cannabinoids that could be extracted (or synthesized) from hemp and have psychoactive effects.
The unintended consequence of the Farm Bill was a surge in hemp-derived products containing intoxicating cannabinoids like delta‑8 THC, delta‑10 THC, and THCa. Because these compounds are usually present in low quantities in raw hemp, they are typically produced via chemical conversion (e.g., converting CBD to delta-8 THC). Courts and agencies have often held that if these compounds originate from legally grown hemp and the delta‑9 THC level is below 0.3%, they are federally legal—even if they produce a potent intoxicating effect.
This “loophole” led to an explosion in availability of psychoactive products outside the highly regulated state cannabis dispensary model. Many states responded with their own bans or new frameworks, but at the federal level, ambiguity persisted.
The HEMP Act of 2025 (S.2112) directly challenges the status quo. According to analysis and legislative tracking (congress.gov text), the bill would:
Key language in the HEMP Act targets chemically converted cannabinoids and closes the door on broad interpretations of "derivatives" that enabled the delta-8/THCa market’s rise. Any product containing cannabinoids synthesized or manufactured outside the cannabis plant, regardless of concentration, would be disqualified from the federal “hemp” definition ([Shipman & Goodwin analysis]).
The HEMP Act is not alone—Congress is exploring several mechanisms to tighten the definition of legal hemp, including amendments in the 2025 appropriations process and upcoming Farm Bill reauthorization. These have included:
Provisions to impose a “total THC” standard and restrict synthetic or converted cannabinoids were advanced by the House Appropriations Committee (see Foley Hoag summary), while the Senate has, for now, stripped or narrowed some of these rules amidst disagreements. The legislative debate is ongoing, but the momentum to crack down on intoxicating hemp remains strong.
If the HEMP Act passes, any product containing intoxicating levels of delta‑8, THCa, or similar cannabinoids would become federally illegal outside the regulated marijuana supply chain. Many currently legal hemp businesses would need to cease production, reformulate, or transition to state-licensed cannabis operations.
Products that are strictly non-intoxicating (CBD, CBG, etc.), with no converted or synthetic cannabinoids present, would likely remain federally legal. However, contamination or manufacturing processes involving conversion could present risk.
The interstate shipping of hemp-derived intoxicating products would instantly become unlawful, and these goods would be subject to DEA and FDA enforcement. Retailers and producers would also lose access to financial services and supply chains previously shielded by hemp’s federal legality.
States could maintain more liberal definitions, but these would conflict with narrowly redefined federal law. Many states already restrict delta‑8/THCa, but a federal ban would dramatically consolidate policy and enforcement nationwide. Conversely, cannabis-friendly states could see increased demand for licensed marijuana products, but pressure on hemp processors.